Mónica G Mendoza-Rodríguez, Daniela Medina-Reyes, Cuauhtémoc A Sánchez-Barrera, Karen V Fernández-Muñoz, Verónica García-Castillo, Jorge L Ledesma-Torres, Marisol I González-González, José L Reyes, Carlos Pérez-Plascencia, Miriam Rodríguez-Sosa, Felipe Vaca-Paniagua, Marco A Meraz, Luis I Terrazas
Colorectal cancer (CRC) is one of the most prevalent fatal neoplasias worldwide. Despite efforts to improve the early diagnosis of CRC, the mortality rate of patients is still nearly 50%. The primary treatment strategy for CRC is surgery, which may be accompanied by chemotherapy and radiotherapy. The conventional and first-line chemotherapeutic agent utilized is 5-fluorouracil (5FU). However, it has low efficiency. Combination treatment with leucovorin and oxaliplatin or irinotecan improves the effectiveness of 5FU therapy...
April 24, 2024: Biomedicine & Pharmacotherapy